Skip to main content Help with accessibility Skip to main navigation

Infliximab

Indication

Juvenile Idiopathic Arthritis (JIA) in Adult Patients
Red

Brand:

Remicade®, Inflectra®, Remsima®

Nice TA:

Commissioning responsibility:

CCG

PbR excluded:

Yes

BNF chapter:
Musculoskeletal system

Background

Treatment with infliximab for adults with JIA is recommended ONLY in the following circumstances in Lancashire and South Cumbria:
Young people with JIA currently being treated with one of the agents and transferring over from adolescent to adult services and are benefiting from a clinically effective response

Recommendation

LSCMMG Recommendation:

Red

Reason for decision:

Specialist medicine

Decisions of Lancashire local decision making groups

Pending
Pending
Red
Pending
Red
Red
Red
Pending
What do the colours mean?

Last Updated: 01 - Jun - 2015